TEMPO.CO, Jakarta - The Food and Drug Monitoring Agency (BPOM) has officially issued an emergency use authorization (EUA) or the distribution permit for the Covid-19 vaccine produced by Bio Farma. The state-owned pharmaceutical firm produced the antibody against coronavirus infection by using raw materials from China’s Sinovac Biotech.
“The vaccine produced by Bio Farma, today, February 16, is approved and will be granted with EUA from BPOM,” said the BPOM Head Penny K Lukito in a press conference, Tuesday, February 16.
The vaccine produced by Bio Farma, Penny added, was registered under the EUA number 2102907543A1.
“This vaccine multi-dose vial may contain up to ten doses of 5 milliliters, is composed of inactivated virus, is packaged in 10 vials, and is stored at 2-8° C,” she explained.
Each vial, Penny continued, is equipped with a barcode for tracking the vaccine and preventing the production of counterfeit antibodies. With the issuance of the EUA, the Covid-19 vaccine produced by Bio Farma could be immediately distributed and injected into the public.